Search - tctmd.com

Displaying 1 - 14 of 14

Sort: Relevancy | Date

News Conference News AHA 2017

TRICS III: Restrictive Red-Cell Transfusion Noninferior to Liberal Use in Cardiac Surgery

Shelley Wood

November 12, 2017

Presentation TCT 2017

Office, Home, or Ambulatory Blood Pressure: How to Measure Blood Pressure in Practice and Clinical Trials

Presenter: Sidney C. Smith, Michael A. Weber, C. Venkata S. Ram

October 30, 2017

Presentation TCT 2017

Recent Clinical Trials and Nonrandomized Studies That Will Change Your Daily Practice

Presenter: Sidney C. Smith, Michael A. Weber, Vasilios Papademetriou

October 30, 2017

News Daily News

Women, Minorities at Greater Risk for Non-Stent-Related Events After PCI

Yael L. Maxwell

October 20, 2017

Presentation

Comparative Outcomes of US Patients With Advanced Renal Dysfunction Undergoing TAVR

October 17, 2017

News Daily News

Excluded From Trials, Patients With Severe Kidney Disease Benefit Less From TAVR

Shelley Wood

October 10, 2017

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for August 2017

Caitlin E. Cox

August 31, 2017

News Daily News

Smoking Cessation Drugs: Missed Opportunity for Patients Hospitalized for CHD

Caitlin E. Cox

August 23, 2017

News Opinion Editor's Corner ESC 2017

ESC 2017: In Tragedy’s Wake, Cardiology’s Biggest Congress Forges On

Shelley Wood

August 18, 2017

Studies Supporting Device Modifications Weak, Often Based on Surrogate Endpoints

News Daily News

FDA Clearance of Modified Devices Relies Heavily on Weak Studies, Surrogate Endpoints

Michael O'Riordan

August 16, 2017

News Daily News

Safety-Net Hospitals Don’t Lag Behind in Terms of Early PCI Outcomes

Ashley Lyles

August 07, 2017

News Daily News

Long-term Ticagrelor Post-MI of ‘Intermediate Value’: Cost-Effectiveness Study

Leah Lawrence

July 24, 2017

News Conference News CRT 2017

Same-Day Discharge After Transradial PCI Safe, Feasible, With Significant Cost Savings

Michael O'Riordan

February 23, 2017

News Daily News

Registry Hints Staged Intervention Reduces Mortality in STEMI Patients With Multivessel CAD, but Controversy Remains

L.A. McKeown

January 09, 2017

Advertisement

TRICS III: Restrictive Red-Cell Transfusion Noninferior to Liberal Use in Cardiac Surgery

Office, Home, or Ambulatory Blood Pressure: How to Measure Blood Pressure in Practice and Clinical Trials

Recent Clinical Trials and Nonrandomized Studies That Will Change Your Daily Practice

Women, Minorities at Greater Risk for Non-Stent-Related Events After PCI

Comparative Outcomes of US Patients With Advanced Renal Dysfunction Undergoing TAVR

Excluded From Trials, Patients With Severe Kidney Disease Benefit Less From TAVR

TCTMD’s Top 10 Most Popular Stories for August 2017

Smoking Cessation Drugs: Missed Opportunity for Patients Hospitalized for CHD

ESC 2017: In Tragedy’s Wake, Cardiology’s Biggest Congress Forges On

FDA Clearance of Modified Devices Relies Heavily on Weak Studies, Surrogate Endpoints

Safety-Net Hospitals Don’t Lag Behind in Terms of Early PCI Outcomes

Long-term Ticagrelor Post-MI of ‘Intermediate Value’: Cost-Effectiveness Study

Same-Day Discharge After Transradial PCI Safe, Feasible, With Significant Cost Savings

Registry Hints Staged Intervention Reduces Mortality in STEMI Patients With Multivessel CAD, but Controversy Remains

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content